What does it mean to think and work like a scientist? How do you turn ideas into experiments? For the fifth time, the BSSA – organized and run by the Biozentrum at the University of Basel – brought together high school…

With the renowned Starting Grants, the SNSF honors excellent young researchers for their innovative research and supports them in consolidating their own research program. Yuping Li is one of the top young researchers to…

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the treatment of diabetes is too low to inhibit cancer growth. The…

The protein complex mTORC1 promotes muscle growth and is important for the self-cleaning process of the muscle cells. The role of mTORC1 in skeletal muscle fibers in response to nerve injury has so far not been studied in…

Ribosomes produce all the body’s proteins and are therefore also referred to as "protein factories". Their architecture and function have largely remained unchanged over millions of years, highlighting their importance for…

The Biozentrum start-up Aukera Therapeutics was selected to join the BaseLaunch Accelerator Program. With its qualification for this program, the biotech venture receives funding of up to 500,000 Swiss francs as well as…

The objectives of the National Center of Competence in Research (NCCR) "AntiResist" are to search for new antibiotics and to develop alternative strategies to combat antibiotic-resistant pathogens. "AntiResist" is one of a…

The issue of intestinal bacteria is a complex one. On the one hand, we are dependent on the microorganisms because they are the ones that digest the food in our intestine. On the other hand, there are also numerous pathogens…

The G protein-coupled receptors (GPCRs) perform very diverse tasks in our body. They enable us to see, taste food, feel cold or warm, or respond to stress. Located on the cell surface, GPCRs sense a large variety of signals…

Santhera Pharmaceuticals has started a collaboration with Prof. Markus Rüegg, who pioneered a novel gene therapy approach for the treatment of type 1 congenital muscular dystrophy (MDC1A). MDC1A is a severe form of…